<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SMF</journal-id>
      <journal-title-group>
        <journal-title>Schweizerisches Medizin-Forum</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1424-4020</issn>
      <issn pub-type="ppub">1424-3784</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">08093</article-id>
      <article-id pub-id-type="doi">10.4414/smf.2019.08093</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Was ist Ihre Diagnose?</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Infektiologie</subject>
          <subject>Labormedizin</subject>
          <subject>Neurologie</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>«Los e’mal …» – ein (nicht so) klarer Fall von Rückenschmerzen
</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Sturzenegger</surname>
            <given-names>Mathias</given-names>
          </name>
          <email/>
          <aff>Freiburgstrasse 30 | Bern | 3010 | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Sendi</surname>
            <given-names>Parham</given-names>
          </name>
          <email/>
          <aff>Institut für Infektionskrankheiten, Universität Bern; Klinik für Infektiologie &amp; Spitalhygiene, Universitätsspital Basel.</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2019.05.08">
        <day>08</day>
        <month>05</month>
        <year>2019</year>
      </pub-date>
      <volume>19</volume>
      <issue>1920</issue>
      <fpage>326</fpage>
      <lpage>331</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Medical Forum" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="de">&lt;p&gt;*	Bei Erwachsenen präsentiert sich die Neuroborreliose hauptsächlich als Meningoradikulitis, wobei der nächtliche, radikuläre, Ruheschmerz sehr typisch ist.
*	Bei Kindern ist eine Fazialis Parese, mit oder ohne Begleitmeningitis die weitaus häufigste Phänomenologie.
*	Enzephalitis, Myelitis oder eine zerebrale Vaskulitis (sogenannte parenchymatöse Manifestationen) sind seltene Manifestationen (&amp;lt; 3 %).
*	Die Neuroborreliose ist einfach und sehr effizient antibiotisch zu behandeln. Ausser bei den parenchymatösen Formen sind orale Antibiotika erste Wahl. Bei rechtzeitiger Behandlung ist die Prognose ausgezeichnet.
*	Chronische oder persistierende Infektionen sind eine exquisite Rarität, wenn sie überhaupt existieren.&lt;/p&gt;</abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
